The role of alemtuzumab in chronic lymphocytic leukaemia patients with p53 defects. Hematol Meeting Rep [Internet]. 2009 Jun. 17 [cited 2025 Jun. 20];1(5). Available from: https://journals.pagepress.org/hmr/article/view/638